Menu

Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients

Status

Completed

Conditions

Breast Cancer
Breast Cancer Female
Breast Neoplasms

Treatments

Procedure: Mastectomy
Procedure: Breast-Conserving Surgery

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Breast cancer is the most common cancer in women across the world, accounting for 25.2% of cancer cases among females and 14.7% of cancer-related deaths among females worldwide. The survival rates are markedly lower in the developing countries compared to developed countries, as well as the age at diagnosis. Core management of breast cancer includes surgical removal of the tumor either by breast-conserving surgery (BCS) or mastectomy (removal of the whole breast). Choosing between these two procedures may be influenced by factors that have yet to be studied in Saudi Arabia. The investigators aimed to determine the prevalence of BCS and mastectomy and the factors that may influence the choice of procedure. This retrospective study was carried out by reviewing the records of female breast cancer patients who underwent BCS or mastectomy at King Abdulaziz University Hospital between 2009 to June 2017, excluding those with metastasis (distant spread of the cancer) or recurrence. Using frequencies for the rate, and multivariate tests, the investigators analyzed different demographic, clinicopathological, and radiological factors to detect correlations with procedure choice.

Enrollment

335 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female, diagnosed with breast cancer, underwent surgery on the breast tumor in King Abdulaziz University Hospital

Exclusion criteria

  • Patients with metastatic breast cancer or recurrence of the cancer before the surgery

Trial design

335 participants in 2 patient groups

Mastectomy
Treatment:
Procedure: Mastectomy
Breast-Conserving Surgery
Treatment:
Procedure: Breast-Conserving Surgery

Trial contacts and locations

1

There are currently no registered sites for this trial.

Timeline

Last updated: Dec 06, 2018

Start date

Jul 17, 2017 • 7 years ago

End date

Aug 02, 2018 • 6 years ago

Today

May 13, 2025

Sponsor of this trial

Data sourced from clinicaltrials.gov